Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty (FacialReinn)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by University Hospital, Caen
Sponsor:
Information provided by (Responsible Party):
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT01833221
First received: April 12, 2013
Last updated: April 8, 2014
Last verified: April 2014
  Purpose

The purpose of this study is to determine the physiology of nerve healing and the neurotization of the facial muscles after lengthening temporalis myoplasty.


Condition Intervention Phase
Facial Paresis
Drug: injection of 1% lidocaine, 2mL for facial nerve block
Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty

Resource links provided by NLM:


Further study details as provided by University Hospital, Caen:

Primary Outcome Measures:
  • Facial muscle contraction after nerve block [ Time Frame: 30 minutes after lidocaoine injection ] [ Designated as safety issue: No ]
    clinical and photographical study will be performed before and after neve block and relative contractibility state will be recorded


Estimated Enrollment: 15
Study Start Date: April 2013
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Neurotized facial muscle patients
injection of 1% lidocaine, 2mL for facial nerve block
Drug: injection of 1% lidocaine, 2mL for facial nerve block
injection with a fine needle of 2mL lidocaine in close contact of the facial nerve trunk
Other Name: facial nerve block following the O'Brien modified technique

Detailed Description:

The investigators want to study the physiology of nerve healing after lengthening temporalis myoplasty done for facial nerve impairment. The investigators already observed few cases of spontaneous neurotization and the investigators want to check the nerve command of the facial muscles. Clinical and photographic evaluations will be performed before and after a facial nerve block using 1% lidocaine.

  Eligibility

Ages Eligible for Study:   6 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient who were operated for a facial paralysis by the lengthening temporalis myoplasty procedure in the University Hospital of Caen and who present signs of contraction of the facial muscles on the plasy side after the procedure.

Exclusion Criteria:

  • Patient with contraindications to the injection of lidocaine
  • Patient treated with beta-blocker
  • Patient on anti-coagulants
  • Pathology cause of facial paralysis evolving
  • Pregnant or lactating
  • Patient incapacitated adult
  • Patient undergoing another study at the same time
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01833221

Contacts
Contact: François FOURNEL 02 31 06 54 88 fournel-f@chu-caen.fr

Locations
France
Centre Hospitalier Universitaire Recruiting
Caen, Basse-normandie, France, 14000
Contact: Daniel Labbe, MD    +33231064815    dr.labbe@wanadoo.fr   
Contact: Hervé Bénateau, MD PhD    +33231064815    benateau-h@chu-caen.fr   
Principal Investigator: Daniel Labbé, MD         
Sub-Investigator: Jean-Philippe Giot, MD         
Sub-Investigator: Hervé Bénateau, MD, PhD         
Sub-Investigator: Jean-François Compère, MD, PhD         
Sponsors and Collaborators
University Hospital, Caen
Investigators
Principal Investigator: Daniel Labbé, MD University Hospital, Caen
  More Information

Publications:
Responsible Party: University Hospital, Caen
ClinicalTrials.gov Identifier: NCT01833221     History of Changes
Other Study ID Numbers: 10-159
Study First Received: April 12, 2013
Last Updated: April 8, 2014
Health Authority: France: Committee for the Protection of Personnes
France: Agence Nationale de Sécurité du Médicament et des produits de santé
France: Direction Générale de la Santé

Keywords provided by University Hospital, Caen:
facial palsy
lengthening temporalis myoplasty
neurotization of facial muscles

Additional relevant MeSH terms:
Facies
Disease Attributes
Pathologic Processes
Lidocaine
Anesthetics
Anesthetics, Local
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Sodium Channel Blockers
Therapeutic Uses
Voltage-Gated Sodium Channel Blockers

ClinicalTrials.gov processed this record on November 24, 2014